3Parissis JT, Nikolaou M, Farmakis D, et al . Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure[J]. Heart , 2008,94(5) :585-589.
4Rutten FH, Cramer MJ, Zuithoff NP, et al . Comparison of B- type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease[J]. Eur J Heart Fail , 2007,9(6- 7) :651-659.
5Chung I, Choudhury A, Lip GY. Platelet activation in acute, decompensated congestive heart failure [J]. Thromb Res, 2007,120(5):709-713.
6Tsiara S, Elisaf M, Jagroop IA, et al . Platelets as predictors of vascular risk: is there a practical index of platelet activity[J]? Clin Appl Thromb Hemost , 2003,9(3) :177-190.
7Jafri SM, Ozawa T, Mammen E, et al. Platelet function, thrombin and fibrinolytic activity in patients with heart failure[J]. Fur Heart J , 1993,14(2):205-212.
8Chung I, Choudhury A, Patel J, et al . Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity [J].J Intern Med , 2008,263(3):313-321.
9Yin WH,Chen JW,Jen HL,ei al. Independent prognostic value of elevat-ed high sensitivity C-reactive protein in chronic heart failure[ J]. AmHeart J,2004:147(5) :931-8.
10Tsira S,Elisaf M,Ja^-oop \h.,et al. Platelets as predictor of vascular risk:is there a practical index of platelet activity[ J]. Clin Appl Thromb Hem-ost,2003;9(3) :177-90.
